Overcoming the Challenges of Ankylosing Spondylitis
Ankylosing spondylitis (AS) advocate Jed Finley details growing up with the condition and shares how its challenges led him to his passion: creating community. (Source: WebMD Health)
Source: WebMD Health - October 10, 2022 Category: Consumer Health News Source Type: news
The Invisibility of Ankylosing Spondylitis
Teacher Ali Cornish details what life is like living with a disease no one else can see. (Source: WebMD Health)
Source: WebMD Health - October 10, 2022 Category: Consumer Health News Source Type: news
Staying Active With Ankylosing Spondylitis
Blogger Charis Hill, a former marathoner, details their diagnosis and how they stay active as their disease progresses. (Source: WebMD Health)
Source: WebMD Health - October 10, 2022 Category: Consumer Health News Source Type: news
Non-Radiographic Axial Spondyloarthritis
Rheumatologist Jonathan Chan, MD, explains how non-radiographic axial spondyloarthritis is different from ankylosing spondylitis. (Source: WebMD Health)
Source: WebMD Health - October 10, 2022 Category: Consumer Health News Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
What Are Causes of Childhood Interstital Lung Disease?
Discussion
Interstitial lung disease in children (chILD) is less understood than adult interstitial lung disease (ILD) and is rare. Prevalence is ~ 0.13 to 16.2 per 100,000 children under age 17 years. chILD is an general term for respiratory disorders that are heterogeneous, chronic and impair lung function. While some define diffuse parenchymal lung disease (DPLD) separately, the term ILD usually encompases DPLD. chILD has variable definitions and is “usually diagnosed if three of the following features are present:
1) respiratory symptoms (cough, rapid and/or difficult breathing, and exercise intolerance),
2) res...
Source: PediatricEducation.org - August 1, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Trial: Rinvoq Effective for Biologic-Refractory Ankylosing Spondylitis
(MedPage Today) -- The JAK inhibitor upadacitinib (Rinvoq) outperformed placebo in ankylosing spondylitis patients whose disease hadn't responded to standard biologic drug therapy, phase III trial data showed.
Almost half of patients receiving... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 5, 2022 Category: Primary Care Source Type: news
Upadacitinib Recommended for Nonradiographic AxSpA in Europe Upadacitinib Recommended for Nonradiographic AxSpA in Europe
The Janus kinase inhibitor is already approved for the treatment of active ankylosing spondylitis in the European Union.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2022 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news
Bimekizumab Tames Active Ankylosing Spondylitis in BE MOBILE 2 Bimekizumab Tames Active Ankylosing Spondylitis in BE MOBILE 2
Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 10, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
PET/MRI provides new insights into knee osteoarthritis
PET/MRI has identified which compartments of the knee may be the best target...Read more on AuntMinnie.comRelated Reading:
PET/MRI superior to MRI for diagnosing prostate cancer
ECR: Hypmed project develops affordable PET/MRI for breast scans
PET/MRI appears safe for pregnant women
PET/MRI can improve diagnosis of peritoneal cancer
PET/MRI proves TNF blockers effective for ankylosing spondylitis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 19, 2022 Category: Radiology Source Type: news
How Serious Is Ankylosing Spondylitis (AS)?
Title: How Serious Is Ankylosing Spondylitis (AS)?Category: Diseases and ConditionsCreated: 7/14/2021 12:00:00 AMLast Editorial Review: 5/18/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 18, 2022 Category: Rheumatology Source Type: news
Upadacitinib Earns FDA Approval for Ankylosing Spondylitis Upadacitinib Earns FDA Approval for Ankylosing Spondylitis
Janus kinase inhibitor offers oral option for patients who have failed treatment.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 2, 2022 Category: Dermatology Tags: Rheumatology News Alert Source Type: news
Rinvoq (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis
Across the two pivotal trials, Rinvoq delivered rapid and meaningful disease control with nearly half of ankylosing spondylitis (AS) patients achieving ASAS40 (51% and 44.5% with Rinvoq versus 26% and 18.2% with placebo) at week 14 compared... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 29, 2022 Category: Drugs & Pharmacology Source Type: news
Will Ankylosing Spondylitis Show Up on an MRI?
Title: Will Ankylosing Spondylitis Show Up on an MRI?Category: Diseases and ConditionsCreated: 3/29/2022 12:00:00 AMLast Editorial Review: 3/29/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 29, 2022 Category: Rheumatology Source Type: news
How Do You Determine if You Have Ankylosing Spondylitis?
Title: How Do You Determine if You Have Ankylosing Spondylitis?Category: Diseases and ConditionsCreated: 3/24/2022 12:00:00 AMLast Editorial Review: 3/24/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 24, 2022 Category: Rheumatology Source Type: news
